364 related articles for article (PubMed ID: 28481898)
1. Zika virus-like particle (VLP) based vaccine.
Boigard H; Alimova A; Martin GR; Katz A; Gottlieb P; Galarza JM
PLoS Negl Trop Dis; 2017 May; 11(5):e0005608. PubMed ID: 28481898
[TBL] [Abstract][Full Text] [Related]
2. Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus.
Garg H; Sedano M; Plata G; Punke EB; Joshi A
J Virol; 2017 Oct; 91(20):. PubMed ID: 28794019
[TBL] [Abstract][Full Text] [Related]
3. Zika virus-like particle vaccine protects AG129 mice and rhesus macaques against Zika virus.
Vang L; Morello CS; Mendy J; Thompson D; Manayani D; Guenther B; Julander J; Sanford D; Jain A; Patel A; Shabram P; Smith J; Alexander J
PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009195. PubMed ID: 33711018
[TBL] [Abstract][Full Text] [Related]
4. Zika Virus-Like Particles Bearing a Covalent Dimer of Envelope Protein Protect Mice from Lethal Challenge.
De Lorenzo G; Tandavanitj R; Doig J; Setthapramote C; Poggianella M; Sanchez-Velazquez R; Scales HE; Edgar JM; Kohl A; Brewer J; Burrone OR; Patel AH
J Virol; 2020 Dec; 95(1):. PubMed ID: 33028720
[TBL] [Abstract][Full Text] [Related]
5. Immunization with phage virus-like particles displaying Zika virus potential B-cell epitopes neutralizes Zika virus infection of monkey kidney cells.
Basu R; Zhai L; Contreras A; Tumban E
Vaccine; 2018 Feb; 36(10):1256-1264. PubMed ID: 29395533
[TBL] [Abstract][Full Text] [Related]
6. Capsid containing virus like particle vaccine against Zika virus made from a stable cell line.
Garg H; Mehmetoglu-Gurbuz T; Ruddy GM; Joshi A
Vaccine; 2019 Nov; 37(48):7123-7131. PubMed ID: 31607605
[TBL] [Abstract][Full Text] [Related]
7. Passive Transfer of Immune Sera Induced by a Zika Virus-Like Particle Vaccine Protects AG129 Mice Against Lethal Zika Virus Challenge.
Espinosa D; Mendy J; Manayani D; Vang L; Wang C; Richard T; Guenther B; Aruri J; Avanzini J; Garduno F; Farness P; Gurwith M; Smith J; Harris E; Alexander J
EBioMedicine; 2018 Jan; 27():61-70. PubMed ID: 29269041
[TBL] [Abstract][Full Text] [Related]
8. An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.
Urakami A; Ngwe Tun MM; Moi ML; Sakurai A; Ishikawa M; Kuno S; Ueno R; Morita K; Akahata W
J Virol; 2017 Dec; 91(23):. PubMed ID: 28956764
[TBL] [Abstract][Full Text] [Related]
9. Zika virus-like particle vaccine fusion loop mutation increases production yield but fails to protect AG129 mice against Zika virus challenge.
Thompson D; Guenther B; Manayani D; Mendy J; Smith J; Espinosa DA; Harris E; Alexander J; Vang L; Morello CS
PLoS Negl Trop Dis; 2022 Jul; 16(7):e0010588. PubMed ID: 35793354
[TBL] [Abstract][Full Text] [Related]
10. Zika virus like particles elicit protective antibodies in mice.
Salvo MA; Kingstad-Bakke B; Salas-Quinchucua C; Camacho E; Osorio JE
PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006210. PubMed ID: 29401460
[TBL] [Abstract][Full Text] [Related]
11. Dengue-2 virus-like particle (VLP) based vaccine elicits the highest titers of neutralizing antibodies when produced at reduced temperature.
Boigard H; Cimica V; Galarza JM
Vaccine; 2018 Nov; 36(50):7728-7736. PubMed ID: 30377067
[TBL] [Abstract][Full Text] [Related]
12. Zika virus-like particles (VLPs): Stable cell lines and continuous perfusion processes as a new potential vaccine manufacturing platform.
Alvim RGF; Itabaiana I; Castilho LR
Vaccine; 2019 Nov; 37(47):6970-6977. PubMed ID: 31164305
[TBL] [Abstract][Full Text] [Related]
13. Zika Virus-Like Particle (VLP) vaccine displaying Envelope (E) protein CD loop antigen elicits protective and specific immune response in a murine model.
Cimica V; Williams S; Adams-Fish D; McMahon C; Narayanan A; Rashid S; Stedman TT
Biochem Biophys Res Commun; 2020 Aug; 529(3):805-811. PubMed ID: 32736711
[TBL] [Abstract][Full Text] [Related]
14. Pichia pastoris-expressed Zika virus envelope domain III on a virus-like particle platform: design, production and immunological evaluation.
Shanmugam RK; Ramasamy V; Shukla R; Arora U; Swaminathan S; Khanna N
Pathog Dis; 2019 Apr; 77(3):. PubMed ID: 31093663
[TBL] [Abstract][Full Text] [Related]
15. Virus Like Particles (VLP) as multivalent vaccine candidate against Chikungunya, Japanese Encephalitis, Yellow Fever and Zika Virus.
Garg H; Mehmetoglu-Gurbuz T; Joshi A
Sci Rep; 2020 Mar; 10(1):4017. PubMed ID: 32132648
[TBL] [Abstract][Full Text] [Related]
16. Zika Virus Baculovirus-Expressed Virus-Like Particles Induce Neutralizing Antibodies in Mice.
Dai S; Zhang T; Zhang Y; Wang H; Deng F
Virol Sin; 2018 Jun; 33(3):213-226. PubMed ID: 29774519
[TBL] [Abstract][Full Text] [Related]
17. Zika Virus Attenuation by Codon Pair Deoptimization Induces Sterilizing Immunity in Mouse Models.
Li P; Ke X; Wang T; Tan Z; Luo D; Miao Y; Sun J; Zhang Y; Liu Y; Hu Q; Xu F; Wang H; Zheng Z
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925661
[TBL] [Abstract][Full Text] [Related]
18. Critical neutralizing fragment of Zika virus EDIII elicits cross-neutralization and protection against divergent Zika viruses.
Tai W; He L; Wang Y; Sun S; Zhao G; Luo C; Li P; Zhao H; Fremont DH; Li F; Jiang S; Zhou Y; Du L
Emerg Microbes Infect; 2018 Jan; 7(1):7. PubMed ID: 29362446
[TBL] [Abstract][Full Text] [Related]
19. Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika Virus Infection and Testis Damage.
Xu K; Song Y; Dai L; Zhang Y; Lu X; Xie Y; Zhang H; Cheng T; Wang Q; Huang Q; Bi Y; Liu WJ; Liu W; Li X; Qin C; Shi Y; Yan J; Zhou D; Gao GF
J Virol; 2018 Mar; 92(6):. PubMed ID: 29298885
[TBL] [Abstract][Full Text] [Related]
20. Vaccine protection against Zika virus from Brazil.
Larocca RA; Abbink P; Peron JP; Zanotto PM; Iampietro MJ; Badamchi-Zadeh A; Boyd M; Ng'ang'a D; Kirilova M; Nityanandam R; Mercado NB; Li Z; Moseley ET; Bricault CA; Borducchi EN; Giglio PB; Jetton D; Neubauer G; Nkolola JP; Maxfield LF; De La Barrera RA; Jarman RG; Eckels KH; Michael NL; Thomas SJ; Barouch DH
Nature; 2016 Aug; 536(7617):474-8. PubMed ID: 27355570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
